✦ LIBER ✦

Phase II study of raltitrexed in combination with oxaliplatin as second line treatment in refractory advanced colorectal cancer

✍ Scribed by Van Cutsem, E.; Van Laethem, J.; Dirix, L.; Humblet, Y.; Van Eygen, K.; Demol, J.; Bleiberg, H.; Verslype, C.; Vermaut, R.; Daems, K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II randomised trial of raltitrexed

✍ Feliu, J; Castañón, C; Salud, A; Mel, J R; Escudero, P; Pelegrín, A; López-Gómez 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 101 KB

‘Tomudex’ (raltitrexed) 4.0 mg/m[2] as s

✍ A. Schulz; D. Garfield; W. Berry; D. Gordon; C. Lowery; M. Smith 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Gemcitabine and oxaliplatin combination

✍ Kyung Hee Lee; Min Kyoung Kim; Yeol Hong Kim; Baek Yeol Ryoo; Ho Yeong Lim; Hong 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 341 KB

Docetaxel and oxaliplatin combination in

✍ Carlo Barone; Michele Basso; Giovanni Schinzari; Carmelo Pozzo; Nunziatina Trigi 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 200 KB

Phase II study of FOLFIRI regimen in pat

✍ Han Ying Bao; Wei Jia Fang; Xiao Chen Zhang; Gen Ming Shi; Sui Huang; Lan Fang Y 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 269 KB

A multicenter phase II clinical study of

✍ Yutaka Ogata; Shoji Tokunaga; Yasunori Emi; Eiji Oki; Hiroshi Saeki; Ken Shirabe 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 188 KB